Sonoma Pharmaceuticals (SNOA) SEC Filings & 10K Form

$2.98 +0.06 (+2.05%)

Closing price 07/3/2025 01:04 PM Eastern

Extended Trading

$2.98 0.00 (0.00%)

As of 07/3/2025 04:18 PM Eastern

Compare

Recent Sonoma Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/28/2025 7:30 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/07/2025 7:30 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/03/2025 1:22 PM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144/A
01/03/2025 1:27 PM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
01/03/2025 1:15 PM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144/A
01/02/2025 2:39 PM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
01/02/2025 10:13 AM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
12/26/2024 2:40 PM	Gottfurcht Grant (Reporting) Sonoma Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
12/20/2024 4:01 PM	Sonoma Pharmaceuticals (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
11/21/2024 3:01 PM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/07/2024 7:36 AM	Sonoma Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
10/22/2024 7:30 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/20/2024 5:00 AM	Sonoma Pharmaceuticals (Filer)	Form 424B5
09/20/2024 5:02 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/28/2024 5:03 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/21/2024 7:30 AM	Sonoma Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/14/2024 7:49 PM	Sonoma Pharmaceuticals (Filer)	Form DEFA14A
08/14/2024 7:53 PM	Sonoma Pharmaceuticals (Filer)	Form DEFA14A
07/24/2024 6:30 AM	Sonoma Pharmaceuticals (Filer)	Form DEFA14A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies

SEC Filings Tools

This page (NASDAQ:SNOA) was last updated on 7/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonoma Pharmaceuticals (SNOA) SEC Filings & 10K Form

Recent Sonoma Pharmaceuticals SEC Filings

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonoma Pharmaceuticals (SNOA) SEC Filings & 10K Form

Recent Sonoma Pharmaceuticals SEC Filings

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools